Categories: Invest

Is QuantumScape stock too risky after guiding higher Capex than expected?

On Wednesday, QuantumScape Corp (BMV:QS) shares plunged by nearly 9% after saying the company expects a higher Capex in FY2022 compared to 2021. The company announced its FQ3 results Wednesday before markets opened, missing the consensus Street estimate for GAAP earnings per share.

QuantumScape posted a GAAP EPS of -$0.13, $0.03 below Street estimates. The company also said it ended the quarter with $1.5 billion in liquidity, including $39 million in warrants exercised during the quarter.

Is it too early to bet on QS stock?


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

From an investment perspective, QuantumScape shares trade at a steep P/B ratio of 6.89, making the stock less attractive to value investors. However, analysts expect the company’s earnings per share to grow by 89% this year.

Therefore, it could potentially be on growth investors’ radar. 

However, although QS shares are down more than 53% this year, the stock is still up more than 88% over the last 12 months.

Therefore, it may be too early to consider betting on QuantumScape’s promising growth given its current valuation.

Source – TradingView

The pullback may not be over

Technically, QuantumScape shares seem to be trading within a descending channel formation in the intraday chart. However, the stock also appears to have advanced to trade closer to the 100-day moving average, pushing the price towards the trendline resistance.

In addition, QS shares still trade several levels off oversold conditions, leaving room for more downward movements. Therefore, investors could target extended declines at about $18.88, or lower at $13.86. 

On the other hand, if the stock completes an upward breakout, it could find resistance at about $27.89, or higher at $32.54.

Is it safe to buy QS stock?

In summary, although QuantumScape shares have plummeted by more than 53% this year, the stock is still up more than 88% over the previous 12 months. 

Therefore, given the company’s steep valuation multiples, it may be best to wait for the price to retest current support levels before betting on its exciting growth prospects.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. Capital.com, simple, easy to use and regulated. Register here >
admin

Share
Published by
admin

Recent Posts

Is there a way for the crypto sector to avoid Bitcoin’s halving-related bear markets?

There is good reason to be afraid. Previous down markets have seen declines in excess…

2 years ago

UPS and FedEx are good dividend stocks, but which should you take?

United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…

2 years ago

Bitfarms sold 3K Bitcoin as part of strategy to improve liquidity and pay debts

Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…

2 years ago

This biotech stock is up 100% on Tuesday: here’s the catalyst

Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…

2 years ago

Japanese film studio announces the production of a series based on crypto

Noma, a Japanese film studio, has announced that it is producing three feature films that…

2 years ago

Bitcoin price taps 5-day highs as Shiba Inu leads altcoin gains

Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…

2 years ago